GlassScriptPhysician profile
Edith J Heine
NPI 1376136887
$8,397.47
in general payments reported to CMS, 2019-2025
44 companies · $2,339 in 2025
The $2,339 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $902 · 2023: $3,264 · 2024: $1,892 · 2025: $2,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,306 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,306.37 |
| Education | $189.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,486.19 | 2022-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $881.11 | 2022-2025 | Fasenra, Breztri, Tezspire |
| Genzyme Corporation | $620.81 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $535.17 | 2022-2025 | Dupixent |
| Amgen INC. | $407.63 | 2023-2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $407.08 | 2022-2025 | Glassia |
| Ani Pharmaceuticals, INC. | $403.52 | 2023-2025 | Purified Cortrophin Gel |
| Jazz Pharmaceuticals INC. | $358.61 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $330.86 | 2022-2025 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $326.91 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Baxter Healthcare | $246.88 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System |
| Mylan Specialty L.P. | $217.56 | 2023-2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $198.63 | 2023-2025 | Acthar |
| Grifols USA, LLC | $187.52 | 2022-2024 | Prolastin-C Liquid |
| Axsome Therapeutics, INC. | $173.26 | 2023-2025 | Sunosi |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $163.88 | 2023-2025 | Vest Therapy Und, Incourage Airway Clearance Therapy |
| Genentech USA, INC. | $139.54 | 2023-2024 | Xolair |
| Avadel Cns Pharmaceuticals, LLC | $116.28 | 2023-2025 | Lumryz |
| Harmony Biosciences LLC | $105.98 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $99.94 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $97.26 | 2022-2024 | Nuzyra |
| United Therapeutics Corporation | $86.16 | 2022-2025 | Tyvaso |
| Inspire Medical Systems, INC. | $85.20 | 2023-2025 | Inspire |
| Pharming Healthcare, INC. | $83.58 | 2022-2024 | Ruconest |
| Verona Pharma, INC. | $70.92 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $64.76 | 2023-2025 | Winrevair |
| Inogen, INC. | $63.96 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Shionogi INC | $53.25 | 2024 | Fetroja |
| Electromed, INC. | $46.36 | 2024 | Smartvest |
| Insmed, INC. | $41.18 | 2023-2025 | Brinsupri, Arikayce |
| Breas Medical, INC. | $36.29 | 2024 | Vivo 45 Ls |
| Pfizer INC. | $29.46 | 2023-2025 | |
| Lilly USA, LLC | $27.95 | 2025 | Zepbound |
| Janssen Pharmaceuticals, INC | $23.49 | 2024 | Xarelto |
| Vifor Pharma, INC. | $21.92 | 2024 | Zemaira |
| Idorsia Pharmaceuticals US INC | $21.12 | 2023 | Quviviq |
| Novo Nordisk INC | $20.76 | 2024 | Wegovy |
| Resmed Corp | $19.82 | 2024 | |
| Qiagen, LLC | $18.56 | 2025 | |
| Viatris Specialty LLC | $17.32 | 2025 | Yupelri |
| Pulmonx Corporation | $16.44 | 2023 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Teva Pharmaceuticals USA, INC. | $15.76 | 2022 | |
| Abbvie INC. | $14.62 | 2024 | |
| Biomerieux INC | $13.97 | 2023 | Nephrocheck Liquid Control Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edith Heine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.